Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anne-Kathrin Knuth"'
Autor:
Anne-Kathrin Knuth, Stefanie Rösler, Barbara Schenk, Lisa Kowald, Sjoerd J.L. van Wijk, Simone Fulda
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 74-81 (2019)
Interferons (IFNs) are key players in the tumor immune response and act by inducing the expression of IFN-stimulated genes (ISGs). Here, we identify the mixed-lineage kinase domain-like pseudokinase (MLKL) as an ISG in various cancer cell lines. Both
Externí odkaz:
https://doaj.org/article/9bf0ec570bf74f28abe3cca90f4d20db
Autor:
Sjoerd J L van Wijk, Anne-Kathrin Knuth, Stefanie Rösler, Barbara Schenk, Lisa Kowald, Simone Fulda
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 74-81 (2019)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Interferons (IFNs) are key players in the tumor immune response and act by inducing the expression of IFN-stimulated genes (ISGs). Here, we identify the mixed-lineage kinase domain-like pseudokinase (MLKL) as an ISG in various cancer cell lines. Both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5938629e1af1e96d676b42488b98ebbd
http://www.sciencedirect.com/science/article/pii/S1476558618304366
http://www.sciencedirect.com/science/article/pii/S1476558618304366
Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines
Autor:
Stefanie Roesler, Simone Fulda, Anne-Kathrin Knuth, Ines Eckhardt, Michael John Cekay, Tanja Frank
Publikováno v:
Cancer letters. 410
Since cancer cells often evade apoptosis, induction of necroptosis as another mode of programmed cell death is considered a promising therapeutic alternative. Here, we identify a novel synergistic interaction of Smac mimetics that antagonize x-linked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0db8a0d7fcdfecbe548a0dd5e576c6c
https://pubmed.ncbi.nlm.nih.gov/28923396
https://pubmed.ncbi.nlm.nih.gov/28923396